Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs.
第一作者:
Brian,Godman
第一单位:
Prescribing Research Group, University of Liverpool Management School, Chatham Street, Liverpool, L69 7ZH, UK. brian.godman@ki.se
作者:
主题词
抗胆固醇血症药(Anticholesteremic Agents);吖丁啶类(Azetidines);药物, 通用名(Drugs, Generic);卫生保健改革(Health Care Reform);卫生政策(Health Policy);人类(Humans);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);保险, 药剂师工作(Insurance, Pharmaceutical Services);挪威(Norway);质子泵抑制剂(Proton Pump Inhibitors);偿还途径(Reimbursement Mechanisms);回顾性研究(Retrospective Studies)
DOI
10.1586/erp.10.87
PMID
21351864
发布时间
2015-11-19
- 浏览22
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



